Search hospitals > Minnesota > Minneapolis
Abbott Northwestern Hospital
Claim this profileMinneapolis, Minnesota 55407
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
Conducts research for Lung Cancer
500 reported clinical trials
25 medical researchers
Summary
Abbott Northwestern Hospital is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Adenocarcinoma, Lung Cancer and other specialties. Abbott Northwestern Hospital is involved with conducting 500 clinical trials across 604 conditions. There are 25 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
David M. KingPark Nicollet Clinic - Saint Louis Park7 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
97 reported clinical trials
159 drugs studied
Daniel M. AndersonRegions Hospital4 years of reported clinical research
Expert in Cancer
Expert in Tumors
60 reported clinical trials
108 drugs studied
Yan JiRegions Hospital1 year of reported clinical research
Expert in Cancer
Studies Breast Cancer
30 reported clinical trials
74 drugs studied
Pamala A. PawloskiPark Nicollet Clinic - Saint Louis Park5 years of reported clinical research
Studies Cancer
Studies Tumors
14 reported clinical trials
19 drugs studied
Clinical Trials running at Abbott Northwestern Hospital
Breast Cancer
Cancer
Prostate Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Gastric Cancer
Multiple Myeloma
Colon Cancer
Esophageal Cancer
Anal Cancer
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Abbott Northwestern Hospital?
Abbott Northwestern Hospital is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Adenocarcinoma, Lung Cancer and other specialties. Abbott Northwestern Hospital is involved with conducting 500 clinical trials across 604 conditions. There are 25 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.
Where is Abbott Northwestern Hospital located?
Abbott Northwestern Hospital is situated at 800 E 28th St, Minneapolis, MN. For access, navigate to the intersection of E 28th St and Chicago Ave. Parking is available in the Purple Ramp, and the temporary main entrance is located at the Main Hospital West Building.
Who should I call to ask about financial aid or insurance network?
**Abbott Northwestern Hospital Financial and Insurance Information:**
- **Financial Assistance:** Contact the Financial Counseling department at **612-863-4385**.
- **Insurance Inquiries:** For any insurance-related questions, please reach out to the Billing department at **612-262-9000**.
What insurance does Abbott Northwestern Hospital accept?
Abbott Northwestern Hospital in Minneapolis, MN, accepts a wide range of insurance plans, including commercial, government, and exchange options. Their network participation includes Blue Cross and Blue Shield of Minnesota, HealthPartners, Medica Health Plans, Medicare, NGS, OPTUM, Preferred One, Tricare, United Healthcare, and UnitedHealthcare Community Plan. It's important to confirm your coverage details with your plan administrator, as out-of-network services may incur higher costs.
What awards or recognition has Abbott Northwestern Hospital received?
Abbott Northwestern Hospital, located in Minneapolis, Minnesota, is renowned for its groundbreaking research aimed at improving and saving lives. It has been rated high performing in two adult specialties and 13 procedures and conditions by U.S. News & World Report. The hospital's services, doctors, and nurses have received national and local acclaim from prestigious organizations including The Joint Commission and the American Nurses Credentialing Center.